A Multi-center,Prospective, OS to Evaluate the Effectiveness of 'NAC' Nebulizer Therapy in COPD (NEWEST)

Efficacy, Safety and Tolerability of NVA237 in Patients With Chronic Obstructive Pulmonary Disease

NCT01566604 ·Status: COMPLETED ·Phase: PHASE3

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Cavosonstat Administered Twice Daily Compared With Placebo for 24 Weeks in Adult Subjects With Chronic Obstructive Pulmonary Disease (COPD)

NCT04600778 ·Status: UNKNOWN ·Phase: PHASE2

Effect on Structural Changes in Airways, Measured by MSCT, of Twice Daily 60mg AZD9668 for 12 Weeks in Chronic Obstructive Pulmonary Disease (COPD) Patients

NCT01054170 ·Status: COMPLETED ·Phase: PHASE2

Treatment of Chronic Obstructive Pulmonary Disease by Infusion of Allogenic Mesenchymal Stem Cells

NCT06491043 ·Status: RECRUITING ·Phase: PHASE2

Efficacy and Safety of NVA237 in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT01119950 ·Status: COMPLETED ·Phase: PHASE2

A Trial to Evaluate the Safety and Efficacy of HL231 Solution for Inhalation in Patients with COPD

NCT06619210 ·Status: COMPLETED ·Phase: PHASE2

Inhaled Amikacin in Preventing AECOPD

NCT05213507 ·Status: UNKNOWN ·Phase: PHASE3

Enhancement of in-Vitro GC Function in Patients With COPD

NCT00241631 ·Status: COMPLETED ·Phase: PHASE2

A Clinical Trial to Compare the Efficacy and Safety of 1-week Treatment of Intravenous N-acetylcysteine (NAC) 600 mg Twice Daily, Ambroxol Hydrochloride 30 mg Twice Daily and Placebo as Expectorant Therapies in Adult Chinese Patients With Respiratory Tract Diseases and Abnormal Mucus Secretions

NCT03843541 ·Status: COMPLETED ·Phase: PHASE3

Staphylococcus and Neisseria Tablets in the Treatment of Acute Exacerbations of Chronic Obstructive Pulmonary Disease.

NCT05543343 ·Status: UNKNOWN ·Phase: NA

A Study to Assess the Efficacy and Safety of HSK31858 in Participants With Non-Cystic Fibrosis Bronchiectasis

NCT06660992 ·Status: RECRUITING ·Phase: PHASE3

Effect of NVA237 on Exercise Endurance in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT01154127 ·Status: COMPLETED ·Phase: PHASE3

Safety and Tolerability of Multiple Inhaled NVA237 Doses in Chronic Obstructive Pulmonary Disease (COPD) Patients

NCT00545311 ·Status: COMPLETED ·Phase: PHASE1

A 24 Week Efficacy Study of Inhaled Umeclidinium (UMEC) in Patients of Chronic Obstructive Pulmonary Disease (COPD) Using a Novel Dry Powder Inhaler (NDPI)

NCT02184611 ·Status: COMPLETED ·Phase: PHASE3

Randomised Open Label Trial of Hypertonic Saline and Carbocisteine in Bronchiectasis (CLEAR)

NCT04140214 ·Status: COMPLETED ·Phase: PHASE3

Antibiotic or Not in Non-purulent Exacerbations of COPD: a Trial of Security and Efficacy

NCT01091493 ·Status: COMPLETED ·Phase: PHASE4

Clinical Study to Assess the Mode of Action of QBW251 in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT04268823 ·Status: TERMINATED ·Phase: PHASE2

Safety and Efficacy of NVA237 as an add-on to Fixed Dose Combination LABA/ICS

NCT01757015 ·Status: WITHDRAWN ·Phase: PHASE3

A Study to Evaluate Efficacy and Safety Profile of Zabofloxacin Tablet 400mg and Moxifloxacin Tablet 400mg

NCT01658020 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate the Safety of Long-Term Use of Perforomist® (Formoterol Fumarate)

NCT01488019 ·Status: COMPLETED ·Phase: PHASE4

A Study to Evaluate the Efficacy and Safety of Ensifentrine for 24 Weeks in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

NCT05743075 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate Efficacy and Safety of Bronpass Tab. in Patients With Chronic Obstructive Pulmonary Disease

NCT06434792 ·Status: RECRUITING ·Phase: PHASE2

NVA237 BID Versus Placebo Twelve-week Efficacy Study

NCT01715298 ·Status: COMPLETED ·Phase: PHASE3

Safety and Tolerability of 28 Days Treatment With Glycopyrronium Bromide (NVA237) (100 or 200 µg Once a Day) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

NCT00510510 ·Status: COMPLETED ·Phase: PHASE2

The Doses of Systemic Steroid in Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD)

NCT01215825 ·Status: COMPLETED